Toshihiro Maeda

Clinicopathological analysis of patients with non-muscle-invasive bladder cancer: prognostic value and clinical reliability of the 2004 WHO classification system.

N. Nishiyama, N. Masumori, H. Kitamura, 2013, Japanese Journal of Clinical Oncology.

Claudin‐4‐targeted therapy using Clostridium perfringens enterotoxin for prostate cancer

N. Masumori, N. Sawada, M. Murata, 2012, The Prostate.

[Use of 2-octylcyanoacrylate tissue glue for skin closure in radical retropubic prostatectomy].

N. Masumori, Toshiaki Tanaka, T. Tsukamoto, 2010, Hinyokika kiyo. Acta urologica Japonica.

Zoledronic acid but not somatostatin analogs exerts anti‐tumor effects in a model of murine prostatic neuroendocrine carcinoma of the development of castration‐resistant prostate cancer

K. Hirata, N. Masumori, H. Kitamura, 2013, The Prostate.

Comparison of 1-day, 2-day, and 3-day administration of antimicrobial prophylaxis in radical prostatectomy

K. Takeyama, M. Matsukawa, Y. Kunishima, 2007, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Clinicopathological analysis of patients with non-muscle-invasive bladder cancer: prognostic value and clinical reliability of the 2004 WHO classification system.

N. Nishiyama, N. Masumori, H. Kitamura, 2013, Japanese Journal of Clinical Oncology.

The potential of neurotensin secreted from neuroendocrine tumor cells to promote gelsolin-mediated invasiveness of prostate adenocarcinoma cells

K. Hirata, N. Masumori, H. Kitamura, 2015, Laboratory Investigation.

Prevention of local symptoms in muscle invasive bladder cancer patients: clinical significance of local radiation therapy

Tetsuya Shindo, N. Masumori, R. Kato, 2023, Supportive Care in Cancer.